Extending the number of years people can live healthy without daily assistance or care is now a social priority. For this purpose, JKiC promotes the development of precision medicine, which enhances the effectiveness of therapies by matching treatment methods more precisely to the condition of each individual patient. Other research and development at JKiC includes microbiomes, designed medical devices, stem cell biology and cell based medicine.
JSR Group research chemists and Keio University medical researchers / doctors cooperatively provide new advanced medical and clinical technologies and materials that can be useful for diagnostic technologies for early detection of diseases, highly effective treatments and pharmaceuticals to treat diseases at early stages before becoming serious or untreatable.
JKiC promotes the life sciences business, which is positioned as a key strategic business of the JSR Group.